상세 보기
자료 필터
자료유형
발행연도
2008 ~ 2026
2008 2026
키워드
언어
선택된 필터
- article
- conference
- book
전체 233건 중 1번부터 10번까지의 결과를 표시합니다.
2026
Article
Nivolumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Korean Patients with HER2-Negative, Untreated, Unresectable Advanced or Recurrent Gastric or Gastroesophageal Junction Cancer: Subgroup Analysis of a Randomized, Multicenter, Double-Blind Phase 3 Trial (ATTRACTION-4)
- 강윤구 ;
- 유민희 ;
- 오도연 ;
- 오상철 ;
- 라선영 ;
- 외 14명
- 2026-07
- Cancer Research and Treatment
- 대한암학회
Article
Phase Ib/II Study of Zanidatamab in Combination with Tislelizumab and Chemotherapy in First-Line HER2-Positive Gastric/Gastroesophageal Junction Adenocarcinoma
- Lee, Keun-Wook ;
- Bai, Li-Yuan ;
- Jung, Minkyu ;
- Ying, Jieer ;
- Im, Young-Hyuck ;
- ... Oh, Sang Cheul ;
- 외 8명
- 2026-01-16
- Clinical Cancer Research
- AMER ASSOC CANCER RESEARCH
Article
Predictors of overall survival in advanced biliary tract cancer in the phase 3 TOPAZ-1 study
- He, Aiwu R. ;
- Bouattour, Mohamed ;
- Gupta, Vineet G. ;
- Evesque, Ludovic ;
- Zhen, David B. ;
- ... Oh, Sang Cheul ;
- 외 10명
- 2026-01
- Hepatology Communications
- LIPPINCOTT WILLIAMS & WILKINS
2025
Article
Health-related quality of life in participants with advanced biliary tract cancer from the randomized phase III KEYNOTE-966 study
- Yoo, Changhoon ;
- Ueno, Makoto ;
- Klumpen, Heinz-Josef ;
- Kelley, Robin Kate ;
- Vogel, Arndt ;
- ... Oh, Sang Cheul ;
- 외 15명
- 2025-09
- Journal of Hepatology
- ELSEVIER
2024
Article
Neoadjuvant Docetaxel, Oxaliplatin, and S-1 Plus Surgery and Adjuvant S-1 for Resectable Advanced Gastric Cancer: Updated Overall Survival Outcomes From Phase III PRODIGY
- Kang, Yoon-Koo ;
- Kim, Hyung-Don ;
- Yook, Jeong Hwan ;
- Park, Young-Kyu ;
- Lee, Jong Seok ;
- ... Oh, Sang Cheul ;
- 외 29명
- 2024-09-01
- Journal of Clinical Oncology
- LIPPINCOTT WILLIAMS & WILKINS
Article
Nivolumab plus chemotherapy in patients with HER2-negative, previously untreated, unresectable, advanced, or recurrent gastric/gastroesophageal junction cancer: 3-year follow-up of the ATTRACTION-4 randomized, double-blind, placebo-controlled, phase 3 trial
- Boku, Narikazu ;
- Omori, Takeshi ;
- Shitara, Kohei ;
- Sakuramoto, Shinichi ;
- Yamaguchi, Kensei ;
- ... Oh, Sang Cheul ;
- 외 17명
- 2024-08-20
- Gastric Cancer
- SPRINGER
Article
Bemarituzumab plus mFOLFOX6 as first-line treatment in East Asian patients with FGFR2b-overexpressing locally advanced or metastatic gastric/gastroesophageal junction cancer: subgroup of FIGHT final analysis
- Kang, Yoon-Koo ;
- Qin, Shukui ;
- Lee, Keun-Wook ;
- Oh, Sang Cheul ;
- Kim, In-Ho ;
- 외 10명
- 2024-06-11
- Gastric Cancer
- SPRINGER
Article
Rivoceranib, a VEGFR-2 inhibitor, monotherapy in previously treated patients with advanced or metastatic gastric or gastroesophageal junction cancer (ANGEL study): an international, randomized, placebo-controlled, phase 3 trial
- Kang, Yoon-Koo ;
- Ryu, Min-Hee ;
- Di Bartolomeo, Maria ;
- Chau, Ian ;
- Yoon, Harry ;
- ... Oh, Sang Chul ;
- 외 12명
- 2024-03
- Gastric Cancer
- SPRINGER
Article
Bemarituzumab as first-line treatment for locally advanced or metastatic gastric/gastroesophageal junction adenocarcinoma: final analysis of the randomized phase 2 FIGHT trial
- Wainberg, Zev A. ;
- Kang, Yoon-Koo ;
- Lee, Keun-Wook ;
- Qin, Shukui ;
- Yamaguchi, Kensei ;
- ... Oh, Sang Cheul ;
- 외 12명
- 2024-02-03
- Gastric Cancer
- SPRINGER
2023
Article
Zolbetuximab plus CAPOX in CLDN18.2-positive gastric or gastroesophageal junction adenocarcinoma: the randomized, phase 3 GLOW trial
- Shah, Manish A. ;
- Shitara, Kohei ;
- Ajani, Jaffer A. ;
- Bang, Yung-Jue ;
- Enzinger, Peter ;
- ... Oh, Sang Cheul ;
- 외 15명
- 2023-08
- Nature Medicine
- NATURE PORTFOLIO
1